The United States Food and Drug Administration (US FDA) had conducted a Pre-Approval Inspection (PAI) of the new injectable facility of Eugia Steriles Private Limited (a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of the Company), situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, from March 28, 2024 to April 05, 2024.
The Unit has now received the Establishment Inspection Report (EIR) and the inspection is closed.
Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1552.05 as compared to the previous close of Rs. 1562.10. The total number of shares traded during the day was 4008 in over 555 trades.
The stock hit an intraday high of Rs. 1567.25 and intraday low of 1550.00. The net turnover during the day was Rs. 6242455.00. |
